Global OTC Anti-Infective Products Market Growth 2022-2028
As the global economy mends, the 2021 growth of OTC Anti-Infective Products will have significant change from previous year. According to our latest study, the global OTC Anti-Infective Products market size is USD million in 2022 from USD 13030 million in 2021, with a change of % between 2021 and 2022. The global OTC Anti-Infective Products market size will reach USD 16610 million in 2028, growing at a CAGR of 3.5% over the analysis period.
The United States OTC Anti-Infective Products market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global OTC Anti-Infective Products market, reaching US$ million by the year 2028. As for the Europe OTC Anti-Infective Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main OTC Anti-Infective Products players cover Bayer, GSK, Teva, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Products Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for OTC Anti-Infective Products by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for OTC Anti-Infective Products by Country/Region, 2017, 2022 & 2028
2.2 OTC Anti-Infective Products Segment by Type
2.2.1 Antifungal
2.2.2 Antibacterial
2.2.3 Antiviral
2.2.4 Antiseptics
2.2.5 Others
2.3 OTC Anti-Infective Products Sales by Type
2.3.1 Global OTC Anti-Infective Products Sales Market Share by Type (2017-2022)
2.3.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2017-2022)
2.3.3 Global OTC Anti-Infective Products Sale Price by Type (2017-2022)
2.4 OTC Anti-Infective Products Segment by Sales Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Anti-Infective Products Sales by Sales Channel
2.5.1 Global OTC Anti-Infective Products Sale Market Share by Sales Channel (2017-2022)
2.5.2 Global OTC Anti-Infective Products Revenue and Market Share by Sales Channel (2017-2022)
2.5.3 Global OTC Anti-Infective Products Sale Price by Sales Channel (2017-2022)
3 Global OTC Anti-Infective Products by Company
3.1 Global OTC Anti-Infective Products Breakdown Data by Company
3.1.1 Global OTC Anti-Infective Products Annual Sales by Company (2020-2022)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Company (2020-2022)
3.2 Global OTC Anti-Infective Products Annual Revenue by Company (2020-2022)
3.2.1 Global OTC Anti-Infective Products Revenue by Company (2020-2022)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Company (2020-2022)
3.3 Global OTC Anti-Infective Products Sale Price by Company
3.4 Key Manufacturers OTC Anti-Infective Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Anti-Infective Products Product Location Distribution
3.4.2 Players OTC Anti-Infective Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for OTC Anti-Infective Products by Geographic Region
4.1 World Historic OTC Anti-Infective Products Market Size by Geographic Region (2017-2022)
4.1.1 Global OTC Anti-Infective Products Annual Sales by Geographic Region (2017-2022)
4.1.2 Global OTC Anti-Infective Products Annual Revenue by Geographic Region
4.2 World Historic OTC Anti-Infective Products Market Size by Country/Region (2017-2022)
4.2.1 Global OTC Anti-Infective Products Annual Sales by Country/Region (2017-2022)
4.2.2 Global OTC Anti-Infective Products Annual Revenue by Country/Region
4.3 Americas OTC Anti-Infective Products Sales Growth
4.4 APAC OTC Anti-Infective Products Sales Growth
4.5 Europe OTC Anti-Infective Products Sales Growth
4.6 Middle East & Africa OTC Anti-Infective Products Sales Growth
5 Americas
5.1 Americas OTC Anti-Infective Products Sales by Country
5.1.1 Americas OTC Anti-Infective Products Sales by Country (2017-2022)
5.1.2 Americas OTC Anti-Infective Products Revenue by Country (2017-2022)
5.2 Americas OTC Anti-Infective Products Sales by Type
5.3 Americas OTC Anti-Infective Products Sales by Sales Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Products Sales by Region
6.1.1 APAC OTC Anti-Infective Products Sales by Region (2017-2022)
6.1.2 APAC OTC Anti-Infective Products Revenue by Region (2017-2022)
6.2 APAC OTC Anti-Infective Products Sales by Type
6.3 APAC OTC Anti-Infective Products Sales by Sales Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country (2017-2022)
7.1.2 Europe OTC Anti-Infective Products Revenue by Country (2017-2022)
7.2 Europe OTC Anti-Infective Products Sales by Type
7.3 Europe OTC Anti-Infective Products Sales by Sales Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Products by Country
8.1.1 Middle East & Africa OTC Anti-Infective Products Sales by Country (2017-2022)
8.1.2 Middle East & Africa OTC Anti-Infective Products Revenue by Country (2017-2022)
8.2 Middle East & Africa OTC Anti-Infective Products Sales by Type
8.3 Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Anti-Infective Products
10.3 Manufacturing Process Analysis of OTC Anti-Infective Products
10.4 Industry Chain Structure of OTC Anti-Infective Products
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Anti-Infective Products Distributors
11.3 OTC Anti-Infective Products Customer
12 World Forecast Review for OTC Anti-Infective Products by Geographic Region
12.1 Global OTC Anti-Infective Products Market Size Forecast by Region
12.1.1 Global OTC Anti-Infective Products Forecast by Region (2023-2028)
12.1.2 Global OTC Anti-Infective Products Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global OTC Anti-Infective Products Forecast by Type
12.7 Global OTC Anti-Infective Products Forecast by Sales Channel
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer OTC Anti-Infective Products Product Offered
13.1.3 Bayer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK OTC Anti-Infective Products Product Offered
13.2.3 GSK OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva OTC Anti-Infective Products Product Offered
13.3.3 Teva OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson OTC Anti-Infective Products Product Offered
13.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 NOVARTIS
13.5.1 NOVARTIS Company Information
13.5.2 NOVARTIS OTC Anti-Infective Products Product Offered
13.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 NOVARTIS Main Business Overview
13.5.5 NOVARTIS Latest Developments
13.6 MYLAN
13.6.1 MYLAN Company Information
13.6.2 MYLAN OTC Anti-Infective Products Product Offered
13.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 MYLAN Main Business Overview
13.6.5 MYLAN Latest Developments
13.7 Sun Pharma
13.7.1 Sun Pharma Company Information
13.7.2 Sun Pharma OTC Anti-Infective Products Product Offered
13.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sun Pharma Main Business Overview
13.7.5 Sun Pharma Latest Developments
13.8 CR SANJIU
13.8.1 CR SANJIU Company Information
13.8.2 CR SANJIU OTC Anti-Infective Products Product Offered
13.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CR SANJIU Main Business Overview
13.8.5 CR SANJIU Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla OTC Anti-Infective Products Product Offered
13.9.3 Cipla OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Lingrui
13.10.1 Lingrui Company Information
13.10.2 Lingrui OTC Anti-Infective Products Product Offered
13.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lingrui Main Business Overview
13.10.5 Lingrui Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. OTC Anti-Infective Products Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. OTC Anti-Infective Products Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antifungal
Table 4. Major Players of Antibacterial
Table 5. Major Players of Antiviral
Table 6. Major Players of Antiseptics
Table 7. Major Players of Others
Table 8. Global OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 9. Global OTC Anti-Infective Products Sales Market Share by Type (2017-2022)
Table 10. Global OTC Anti-Infective Products Revenue by Type (2017-2022) & ($ million)
Table 11. Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2022)
Table 12. Global OTC Anti-Infective Products Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 14. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2022)
Table 15. Global OTC Anti-Infective Products Revenue by Sales Channel (2017-2022)
Table 16. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2022)
Table 17. Global OTC Anti-Infective Products Sale Price by Sales Channel (2017-2022) & (US$/Unit)
Table 18. Global OTC Anti-Infective Products Sales by Company (2020-2022) & (M Units)
Table 19. Global OTC Anti-Infective Products Sales Market Share by Company (2020-2022)
Table 20. Global OTC Anti-Infective Products Revenue by Company (2020-2022) ($ Millions)
Table 21. Global OTC Anti-Infective Products Revenue Market Share by Company (2020-2022)
Table 22. Global OTC Anti-Infective Products Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers OTC Anti-Infective Products Producing Area Distribution and Sales Area
Table 24. Players OTC Anti-Infective Products Products Offered
Table 25. OTC Anti-Infective Products Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global OTC Anti-Infective Products Sales by Geographic Region (2017-2022) & (M Units)
Table 29. Global OTC Anti-Infective Products Sales Market Share Geographic Region (2017-2022)
Table 30. Global OTC Anti-Infective Products Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global OTC Anti-Infective Products Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global OTC Anti-Infective Products Sales by Country/Region (2017-2022) & (M Units)
Table 33. Global OTC Anti-Infective Products Sales Market Share by Country/Region (2017-2022)
Table 34. Global OTC Anti-Infective Products Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global OTC Anti-Infective Products Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 37. Americas OTC Anti-Infective Products Sales Market Share by Country (2017-2022)
Table 38. Americas OTC Anti-Infective Products Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas OTC Anti-Infective Products Revenue Market Share by Country (2017-2022)
Table 40. Americas OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 41. Americas OTC Anti-Infective Products Sales Market Share by Type (2017-2022)
Table 42. Americas OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 43. Americas OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2022)
Table 44. APAC OTC Anti-Infective Products Sales by Region (2017-2022) & (M Units)
Table 45. APAC OTC Anti-Infective Products Sales Market Share by Region (2017-2022)
Table 46. APAC OTC Anti-Infective Products Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC OTC Anti-Infective Products Revenue Market Share by Region (2017-2022)
Table 48. APAC OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 49. APAC OTC Anti-Infective Products Sales Market Share by Type (2017-2022)
Table 50. APAC OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 51. APAC OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2022)
Table 52. Europe OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 53. Europe OTC Anti-Infective Products Sales Market Share by Country (2017-2022)
Table 54. Europe OTC Anti-Infective Products Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe OTC Anti-Infective Products Revenue Market Share by Country (2017-2022)
Table 56. Europe OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 57. Europe OTC Anti-Infective Products Sales Market Share by Type (2017-2022)
Table 58. Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 59. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2022)
Table 60. Middle East & Africa OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 61. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa OTC Anti-Infective Products Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 65. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 67. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Products
Table 69. Key Market Challenges & Risks of OTC Anti-Infective Products
Table 70. Key Industry Trends of OTC Anti-Infective Products
Table 71. OTC Anti-Infective Products Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. OTC Anti-Infective Products Distributors List
Table 74. OTC Anti-Infective Products Customer List
Table 75. Global OTC Anti-Infective Products Sales Forecast by Region (2023-2028) & (M Units)
Table 76. Global OTC Anti-Infective Products Sales Market Forecast by Region
Table 77. Global OTC Anti-Infective Products Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global OTC Anti-Infective Products Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas OTC Anti-Infective Products Sales Forecast by Country (2023-2028) & (M Units)
Table 80. Americas OTC Anti-Infective Products Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC OTC Anti-Infective Products Sales Forecast by Region (2023-2028) & (M Units)
Table 82. APAC OTC Anti-Infective Products Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe OTC Anti-Infective Products Sales Forecast by Country (2023-2028) & (M Units)
Table 84. Europe OTC Anti-Infective Products Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa OTC Anti-Infective Products Sales Forecast by Country (2023-2028) & (M Units)
Table 86. Middle East & Africa OTC Anti-Infective Products Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global OTC Anti-Infective Products Sales Forecast by Type (2023-2028) & (M Units)
Table 88. Global OTC Anti-Infective Products Sales Market Share Forecast by Type (2023-2028)
Table 89. Global OTC Anti-Infective Products Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global OTC Anti-Infective Products Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global OTC Anti-Infective Products Sales Forecast by Sales Channel (2023-2028) & (M Units)
Table 92. Global OTC Anti-Infective Products Sales Market Share Forecast by Sales Channel (2023-2028)
Table 93. Global OTC Anti-Infective Products Revenue Forecast by Sales Channel (2023-2028) & ($ Millions)
Table 94. Global OTC Anti-Infective Products Revenue Market Share Forecast by Sales Channel (2023-2028)
Table 95. Bayer Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer OTC Anti-Infective Products Product Offered
Table 97. Bayer OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Bayer Main Business
Table 99. Bayer Latest Developments
Table 100. GSK Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 101. GSK OTC Anti-Infective Products Product Offered
Table 102. GSK OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. GSK Main Business
Table 104. GSK Latest Developments
Table 105. Teva Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva OTC Anti-Infective Products Product Offered
Table 107. Teva OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Teva Main Business
Table 109. Teva Latest Developments
Table 110. Johnson & Johnson Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 111. Johnson & Johnson OTC Anti-Infective Products Product Offered
Table 112. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Johnson & Johnson Main Business
Table 114. Johnson & Johnson Latest Developments
Table 115. NOVARTIS Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 116. NOVARTIS OTC Anti-Infective Products Product Offered
Table 117. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. NOVARTIS Main Business
Table 119. NOVARTIS Latest Developments
Table 120. MYLAN Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 121. MYLAN OTC Anti-Infective Products Product Offered
Table 122. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. MYLAN Main Business
Table 124. MYLAN Latest Developments
Table 125. Sun Pharma Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 126. Sun Pharma OTC Anti-Infective Products Product Offered
Table 127. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Sun Pharma Main Business
Table 129. Sun Pharma Latest Developments
Table 130. CR SANJIU Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 131. CR SANJIU OTC Anti-Infective Products Product Offered
Table 132. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. CR SANJIU Main Business
Table 134. CR SANJIU Latest Developments
Table 135. Cipla Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 136. Cipla OTC Anti-Infective Products Product Offered
Table 137. Cipla OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Cipla Main Business
Table 139. Cipla Latest Developments
Table 140. Lingrui Basic Information, OTC Anti-Infective Products Manufacturing Base, Sales Area and Its Competitors
Table 141. Lingrui OTC Anti-Infective Products Product Offered
Table 142. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Lingrui Main Business
Table 144. Lingrui Latest Developments
List of Figures
Figure 1. Picture of OTC Anti-Infective Products
Figure 2. OTC Anti-Infective Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Anti-Infective Products Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global OTC Anti-Infective Products Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. OTC Anti-Infective Products Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antifungal
Figure 10. Product Picture of Antibacterial
Figure 11. Product Picture of Antiviral
Figure 12. Product Picture of Antiseptics
Figure 13. Product Picture of Others
Figure 14. Global OTC Anti-Infective Products Sales Market Share by Type in 2021
Figure 15. Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2022)
Figure 16. OTC Anti-Infective Products Consumed in Hospital Pharmacies
Figure 17. Global OTC Anti-Infective Products Market: Hospital Pharmacies (2017-2022) & (M Units)
Figure 18. OTC Anti-Infective Products Consumed in Retail Pharmacies
Figure 19. Global OTC Anti-Infective Products Market: Retail Pharmacies (2017-2022) & (M Units)
Figure 20. OTC Anti-Infective Products Consumed in Online Pharmacies
Figure 21. Global OTC Anti-Infective Products Market: Online Pharmacies (2017-2022) & (M Units)
Figure 22. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2022)
Figure 23. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel in 2021
Figure 24. OTC Anti-Infective Products Revenue Market by Company in 2021 ($ Million)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Company in 2021
Figure 26. Global OTC Anti-Infective Products Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global OTC Anti-Infective Products Revenue Market Share by Geographic Region in 2021
Figure 28. Global OTC Anti-Infective Products Sales Market Share by Region (2017-2022)
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Country/Region in 2021
Figure 30. Americas OTC Anti-Infective Products Sales 2017-2022 (M Units)
Figure 31. Americas OTC Anti-Infective Products Revenue 2017-2022 ($ Millions)
Figure 32. APAC OTC Anti-Infective Products Sales 2017-2022 (M Units)
Figure 33. APAC OTC Anti-Infective Products Revenue 2017-2022 ($ Millions)
Figure 34. Europe OTC Anti-Infective Products Sales 2017-2022 (M Units)
Figure 35. Europe OTC Anti-Infective Products Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa OTC Anti-Infective Products Sales 2017-2022 (M Units)
Figure 37. Middle East & Africa OTC Anti-Infective Products Revenue 2017-2022 ($ Millions)
Figure 38. Americas OTC Anti-Infective Products Sales Market Share by Country in 2021
Figure 39. Americas OTC Anti-Infective Products Revenue Market Share by Country in 2021
Figure 40. United States OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC OTC Anti-Infective Products Sales Market Share by Region in 2021
Figure 45. APAC OTC Anti-Infective Products Revenue Market Share by Regions in 2021
Figure 46. China OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 50. India OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe OTC Anti-Infective Products Sales Market Share by Country in 2021
Figure 53. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2021
Figure 54. Germany OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 55. France OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country in 2021
Figure 60. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country in 2021
Figure 61. Egypt OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country OTC Anti-Infective Products Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of OTC Anti-Infective Products in 2021
Figure 67. Manufacturing Process Analysis of OTC Anti-Infective Products
Figure 68. Industry Chain Structure of OTC Anti-Infective Products
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
